Cornerstone Advisory LLC trimmed its holdings in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 1.2% during the first quarter, Holdings Channel.com reports. The firm owned 150,539 shares of the company’s stock after selling 1,762 shares during the quarter. Cornerstone Advisory LLC’s holdings in BlackRock Health Sciences Trust were worth $5,505,000 as of its most recent filing with the SEC.
Other large investors also recently modified their holdings of the company. Yakira Capital Management Inc. acquired a new position in BlackRock Health Sciences Trust during the fourth quarter worth about $322,000. Invesco Ltd. grew its holdings in BlackRock Health Sciences Trust by 8.9% during the fourth quarter. Invesco Ltd. now owns 223,316 shares of the company’s stock worth $8,470,000 after acquiring an additional 18,213 shares during the period. Raymond James Financial Inc. acquired a new position in BlackRock Health Sciences Trust during the fourth quarter worth about $3,250,000. NewEdge Advisors LLC grew its holdings in BlackRock Health Sciences Trust by 6.5% during the fourth quarter. NewEdge Advisors LLC now owns 14,388 shares of the company’s stock worth $546,000 after acquiring an additional 880 shares during the period. Finally, First Trust Advisors LP grew its holdings in BlackRock Health Sciences Trust by 6.1% during the fourth quarter. First Trust Advisors LP now owns 6,856 shares of the company’s stock worth $260,000 after acquiring an additional 393 shares during the period.
BlackRock Health Sciences Trust Stock Up 0.7%
NYSE:BME opened at $36.43 on Friday. The business’s 50-day moving average price is $36.12 and its 200 day moving average price is $37.65. BlackRock Health Sciences Trust has a 52-week low of $34.18 and a 52-week high of $42.64.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Trust
- The Significance of Brokerage Rankings in Stock Selection
- Crypto Skeptics Can Still Win Big With These Risk-Limiting ETFs
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Discounted Steel Stocks You Can DCA Into Today
- Top Biotech Stocks: Exploring Innovation Opportunities
- Could Baker Hughes Be an Unlikely Winner in Drone Defense Boom?
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.